Get the Stockscreener App
7.96
0.50%
-0.04
After Hours:
7.96
Avadel Pharmaceuticals Plc Stock (AVDL) Latest News
Avadel Pharmaceuticals at Leerink Conference: Strategic Growth Plans By Investing.com - Investing.com UK
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Average Rating of “Buy” from Analysts - Defense World
Avadel Pharmaceuticals (AVDL) Stock Price, News & Analysis - MarketBeat
HC Wainwright Issues Pessimistic Outlook for AVDL Earnings - Defense World
Avadel Pharmaceuticals Announces Executive Equity Grants By Investing.com - Investing.com South Africa
Avadel Pharmaceuticals Announces Executive Equity Grants - Investing.com
Avadel Pharmaceuticals Plc to Host Earnings Call - accessnewswire.com
Avadel Pharmaceuticals PLC Sponsored ADR to Host Earnings Call - ACCESS Newswire
What is HC Wainwright’s Forecast for AVDL Q3 Earnings? - Defense World
What is Lifesci Capital’s Forecast for AVDL Q2 Earnings? - Defense World
Oppenheimer & Co. Inc. Boosts Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - MarketBeat
Sanctuary Advisors LLC Takes Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Rhumbline Advisers Increases Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
What is Lifesci Capital’s Estimate for AVDL Q1 Earnings? - Defense World
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences - The Manila Times
New York State Common Retirement Fund Sells 389,555 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals (NASDAQ:AVDL) Given “Buy” Rating at HC Wainwright - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2024 Earnings Call Transcript - MSN
Deutsche Bank Adjusts Avadel Pharmaceuticals Price Target to $13 From $12, Maintains Buy Rating - Marketscreener.com
Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Avadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from Needham & Company LLC - Defense World
Avadel Pharmaceuticals Reports Strong Growth in 2024 - TipRanks
Oppenheimer maintains Avadel Outperform rating, $22 target By Investing.com - Investing.com UK
Earnings call transcript: Avadel Pharmaceuticals Q4 2024 reveals revenue miss - Investing.com India
Avadel Pharma earnings missed by $0.03, revenue fell short of estimates - Investing.com Australia
Avadel Pharmaceuticals PLC reports results for the quarter ended December 31Earnings Summary - TradingView
AVADEL PHARMACEUTICALS PLC SEC 10-K Report - TradingView
Avadel: Q4 Earnings Snapshot - CTPost
Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Avadel Pharmaceuticals Reiterates 2025 Guidance -March 03, 2025 at 07:16 am EST - Marketscreener.com
Is Avadel Pharmaceuticals plc (AVDL) the Best Small Cap Pharma Stocks to Buy Now? - Insider Monkey
Avadel Pharmaceuticals (AVDL) Expected to Announce Earnings on Monday - Defense World
Avadel Pharmaceuticals PLC expected to post a loss of 4 cents a shareEarnings Preview - TradingView
Avadel Pharmaceuticals hires new VP of Sales amid narcolepsy drug push - Investing.com Australia
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3 - The Manila Times
Avadel Pharmaceuticals to Provide a Corporate Update and Report - WICZ
Avadel Pharmaceuticals plc (AVDL) may enjoy gains as insiders got busy in the recent days - Knox Daily
Avadel Pharmaceuticals hires new VP of Sales amid narcolepsy drug push By Investing.com - Investing.com South Africa
Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales - The Manila Times
Can This Pharma Veteran Drive Avadel's Billion-Dollar Narcolepsy Drug Success? - StockTitan
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Avadel Announces Grant Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4) - Marketscreener.com
Avadel Pharmaceuticals plc [AVDL] Records 200-Day SMA of $13.29 - Knox Daily
Inside Avadel's Latest Strategic Move: Key Details of New Employee Compensation Plan - StockTitan
3 Stocks With Robust Growth Outlooks Insiders Are Buying - Benzinga
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Short Interest Update - Defense World
Avadel Pharmaceuticals director Linda Palczuk acquires $39,640 in shares - MSN
(AVDL) On The My Stocks Page - Stock Traders Daily
3.49%
2.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):